TROX · Insider Trading
TRONOX LIMITED CL A ORDINARY SHARES
Every open-market purchase and sale reported by TROX officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-31 | Keith Schwarz | Director | A | +18,262 | — |
| 2026-03-09 | Jean Francois Turgeon | Director | Sell | −18,563 | −$122.49K |
| 2026-03-09 | Jeffrey N Neuman | SVP, General Counsel & Sec. | Sell | −22,965 | −$151.44K |
| 2026-03-09 | John Srivisal | SVP, Chief Financial Officer | Sell | −19,461 | −$128.30K |
| 2026-03-09 | John D Romano | CEO and Director | Sell | −101,600 | −$669.64K |
| 2026-03-09 | Jeffrey A. Engle | SVP, Chief Commercial Officer | Sell | −14,575 | −$96.14K |
| 2026-03-09 | Jonathan Flood | Principal Accounting Officer | Sell | −15,008 | −$105.58K |
| 2026-02-13 | John D Romano | CEO and Director | A | +341,855 | — |
| 2026-02-13 | John Srivisal | SVP, Chief Financial Officer | A | +61,855 | — |
| 2026-02-13 | Jeffrey A. Engle | Chief Commercial Officer | A | +42,900 | — |
| 2026-02-13 | Jeffrey N Neuman | SVP, General Counsel & Sec. | A | +63,530 | — |
| 2026-02-13 | Jonathan Flood | Principal Accounting Officer | A | +55,572 | — |
| 2025-08-13 | Peter Johnston | Director | Buy | +20,000 | +$64.20K |
| 2025-08-08 | Jean Francois Turgeon | Director | Buy | +31,150 | +$100.03K |
| 2025-08-07 | Stephen J Jones | Director | Buy | +8,000 | +$25.48K |
| 2025-08-07 | Stephen J Jones | Director | Buy | +7,000 | +$22.38K |
| 2025-08-06 | Stephen J Jones | Director | Buy | +6,000 | +$19.92K |
| 2025-08-01 | John Srivisal | SVP, Chief Financial Officer | Buy | +37,000 | +$125.48K |
| 2025-08-01 | Jeffrey A. Engle | SVP, Commercial and Strategy | Buy | +12,600 | +$38.68K |
| 2025-08-01 | John D Romano | CEO and Director | Buy | +100,000 | +$308.93K |
| 2025-05-09 | Ilan Kaufthal | Director | MIXED | +26,112 | −$5.46K |
| 2025-05-09 | Julie A Beck | Director | A | +32,940 | — |
| 2025-05-09 | Ginger M Jones | Director | MIXED | +26,502 | −$3.54K |
| 2025-05-09 | Jean Francois Turgeon | Director | MIXED | +22,063 | −$25.34K |
| 2025-05-09 | Jeffrey N Neuman | SVP, General Counsel & Sec. | Buy | +10,266 | +$50.20K |
| 2025-05-09 | - De Ridder Lucrece Foufopoulos | Director | MIXED | +26,061 | −$5.71K |
| 2025-05-09 | Sipho Abednego Nkosi | Director | MIXED | +26,129 | −$5.37K |
| 2025-05-09 | Peter Johnston | Director | MIXED | +26,634 | −$2.89K |
| 2025-05-09 | Moazzam A. Khan | Director | MIXED | +22,107 | −$25.12K |
| 2025-05-09 | Stephen J Jones | Director | MIXED | +26,502 | −$3.54K |
| 2025-03-19 | Stephen J Jones | Director | Buy | +30,000 | +$215.13K |
| 2025-03-07 | Jeffrey A. Engle | SVP, Commercial and Strategy | F | −8,846 | −$63.96K |
| 2025-03-07 | John D Romano | CEO and Director | F | −49,877 | −$360.61K |
| 2025-03-07 | Jeffrey N Neuman | SVP, General Counsel & Sec. | F | −16,176 | −$116.95K |
| 2025-03-07 | Jean Francois Turgeon | Director | F | −25,444 | −$183.96K |
| 2025-03-07 | John Srivisal | SVP, Chief Financial Officer | F | −11,267 | −$81.46K |
| 2025-03-07 | Jonathan Flood | Principal Accounting Officer | F | −4,587 | −$33.16K |
| 2025-02-21 | Jeffrey A. Engle | SVP, Commercial and Strategy | A | +44,763 | — |
| 2025-02-21 | John Srivisal | SVP, Chief Financial Officer | A | +64,541 | — |
| 2025-02-21 | Jonathan Flood | Principal Accounting Officer | A | +19,329 | — |
| 2025-02-21 | Jeffrey N Neuman | SVP, General Counsel & Sec. | A | +66,289 | — |
| 2025-02-21 | John D Romano | CEO and Director | A | +341,191 | — |
| 2024-05-09 | Moazzam A. Khan | Director | MIXED | −260 | −$164.73K |
| 2024-05-09 | Mutlaq Hamad Al-Morished | Director | A | +8,324 | — |
| 2024-05-09 | Stephen J Jones | Director | MIXED | +7,076 | −$23.95K |
| 2024-05-09 | Sipho Abednego Nkosi | Director | MIXED | +6,458 | −$35.81K |
| 2024-05-09 | Peter Johnston | Director | MIXED | +7,142 | −$22.68K |
| 2024-05-09 | Jean Francois Turgeon | Director | A | +9,156 | — |
| 2024-05-09 | Ginger M Jones | Director | MIXED | +7,076 | −$23.95K |
| 2024-05-09 | - De Ridder Lucrece Foufopoulos | Director | A | +8,324 | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| John D Romano | CEO and Director | 1,573,740 | $5.46M |
| Jean Francois Turgeon | Director | 754,009 | $2.62M |
| John Srivisal | SVP, Chief Financial Officer | 279,677 | $970.48K |
| Ilan Kaufthal | Director | 267,121 | $926.91K |
| Jeffrey N Neuman | SVP, General Counsel & Sec. | 259,097 | $899.07K |
| Peter Johnston | Director | 191,513 | $664.55K |
| Jeffrey A. Engle | SVP, Chief Commercial Officer | 175,251 | $608.12K |
| Stephen J Jones | Director | 138,414 | $480.30K |
| Jonathan Flood | Principal Accounting Officer | 100,869 | $350.02K |
| Ginger M Jones | Director | 96,847 | $336.06K |
| Sipho Abednego Nkosi | Director | 88,038 | $305.49K |
| Moazzam A. Khan | Director | 37,270 | $129.33K |
| - De Ridder Lucrece Foufopoulos | Director | 34,385 | $119.32K |
| Julie A Beck | Director | 32,940 | $114.30K |
| Keith Schwarz | Director | 18,262 | $63.37K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the TROX quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.